Patent · US Active

Pyrimidine derivatives for the treatment of viral infections

US10420767B2 · kind B2 · utility

3Cited by

32References

18Claims

0Family size

Assignee

Janssen Sciences Ireland UC · IE

Inventors

David Craig McGowan · Vilvoorde, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Werner Constant Johan Embrechts · Beerse, BE
Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
Stefaan Julien Last · Lint, BE
Serge Maria Aloysius Pieters · Wichelen, BE
Jaromir Vlach · Bonneville, FR

Key dates

Filing date	Jan 10, 2018
Grant date	Sep 24, 2019
Priority date	—
Expiry date	Jan 10, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections such as HCV or HBV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.